Cancer News
Sunitinib: First Drug Active in Refractory Meningioma

Spiritual Needs of Cancer Patients Important Part of Care

Never Too Late for Exercise to Cut Breast Cancer Risk

Clues for When to Suspect High-Mitotic-Rate Melanoma

Botox Prevents Development, Spread of Gastric Cancer
Surgery associated with better survival for patients with advanced laryngeal cancer

Genetics and lifestyle have a strong impact on biomarkers for inflammation and cancer

NSAIDs may halve breast cancer recurrence in overweight women

Blueprint for the next generation of chronic myeloid leukemia treatment

NICE clears path for patient access to Revlimid® (lenalidomide) for rare form of blood cancer
Fewer U.S. Teens Using Sunscreen, Study Finds

Study: Many Seniors Get Unnecessary Cancer Tests

HPV Vaccine Protects Against Infection 8 Years Out: Study

Exercise Helps Protect Black Women From Breast Cancer, Study Says

Avastin Approved for Late-Stage Cervical Cancer
JCCC Scientist Honored with Prestigious Biomedical Science Award

PROFILE: Dr. Denis Evseenko—Harnessing the Regenerative Power of Stem Cells in Cancer Research

Four Community Leaders Join Jonsson Cancer Center Foundation Board of Directors

UCLA's Jonsson Comprehensive Cancer Center Once Again Ranks Among Top 10 Cancer Centers Nationwide

Novel Robot-Assisted Surgery Technique Improves Removal of Small Kidney Cancer Tumors
Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation

Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers

Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma

Bone complications among prostate cancer survivors: Long-term follow-up from the prostate cancer outcomes study

Extraprostatic extension of prostatic carcinoma: Is its proximity to surgical margin or gleason score important?